Related Experiment Video
Updated: Jul 24, 2025
08:50
Scalable Biomanufacturing Workflow to Produce and Isolate Natural Killer Cell-Derived Extracellular Vesicle-Based Cancer Biotherapeutics
Published on: August 16, 2024
778
Genetically Engineered-Cell-Membrane Nanovesicles for Cancer Immunotherapy
Qinzhen Cheng1, Yong Kang2, Bin Yao2
1Jinhua Municipal Central Hospital, Jinhua, 321000, China.
Summary
Genetically engineered cell membrane nanovesicles (GCMNs) improve cancer immunotherapy by enhancing targeting and efficacy. This review covers GCMN engineering, preparation, and applications for improved cancer treatment.
Area of Science:
- Biomedical Engineering
- Immunology
- Nanotechnology
Background:
- Immunotherapy represents a significant advancement in cancer treatment.
- Cell membrane nanovesicles (CMNs) offer biocompatible drug delivery but face limitations in targeting and efficacy.
- Genetic engineering presents a strategy to overcome CMN limitations.
Purpose of the Study:
- To provide an overview of surface engineering strategies for CMNs.
- To discuss the features of various membrane sources for CMN preparation.
- To describe the preparation methods for genetically engineered-CMNs (GCMNs).
- To address the applications of GCMNs in cancer immunotherapy and their clinical translation challenges.
Main Methods:
- Surface modification of CMNs using genetic engineering.
- Characterization of different cell membrane sources.
- Development of GCMN preparation protocols.
- Evaluation of GCMN efficacy in targeting various immune cells.
Main Results:
- Genetically engineered CMNs (GCMNs) demonstrate enhanced targeting ability and efficacy compared to traditional CMNs.
- Surface functionalization via genetic engineering allows for tailored GCMN properties.
- GCMNs show promise in directing cancer immunotherapy towards specific immune targets.
Conclusions:
- GCMNs represent a promising platform for advanced cancer immunotherapy.
- Further research into GCMN preparation and clinical translation is warranted.
- Genetic engineering significantly enhances the therapeutic potential of cell membrane-based nanovesicles.
Related Concept Videos
01:27Tumor Immunotherapy
573
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
573
01:30Cancer Vaccines
428
Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
428